Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

Author： Comella Pasquale   Lorusso Vito   Maiorino Luigi   Casaretti Rossana   Cannone Michele   Massidda Bruno   Putzu Carlo   Leo Silvana   Roselli Mario   Mancarella Sergio   Palmeri Sergio   Greco Ettore   Vessia Giacomo   Sandomenico Claudia   Franco Luca  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.64, Iss.5, 2009-10, pp. : 893-899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

By Gubanski Michael   Johnsson Anders   Fernebro Eva   Kadar Lianna   Karlberg Ingegerd   Flygare Petra   Berglund Åke   Glimelius Bengt   Lind Pehr  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Trial of Oxaliplatin, Folinic Acid, and 5-Fluorouracil (FOLFOX4) as First-Line Chemotherapy in Advanced Colorectal Cancer: A China Single-Center Experience

By Xu Nong   Fang Wei-Jia   Zhang Xiao-Chen   Yu Lan-Fang   Bao Han-Ying   Shi Gen-Ming   Huang Sui   Shen Peng  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: A multicenter phase II study by the cancer therapeutic research group

By Ho Wing   Ma B.   Mok Tony   Yeo W.   Lai Paul   Lim R.   Koh Jane   Wong Y.   King Ann   Leow C.   Chan A.  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 303-312

Humana Press, Inc

Access to resources Recommend Favorite

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

By Zhu Xiaodong   Leaw Jiin   Gu Weilie   Qian Yiying   Du Hongyu   Wang Biyun   Hong Xiaonan   Yin Jiliang  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 929-936

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

By Hamaguchi Tetsuya  

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 226-233

Springer Publishing Company

Access to resources Recommend Favorite